Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-25.93%
Shrank
—
—
Shrank
—
1 Year
Score—
Net Growth-25.93%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendShrank
Revenue Consistency—
5 Years
—
-187.73%
20%
—
—
Never
—
5 Years
Score—
Net Growth-187.73%
Net Trend20%
Net Income Consistency—
Rev Growth—
Rev TrendNever
Revenue Consistency—
Olema Pharmaceuticals Inc fundamental performance
Across Olema Pharmaceuticals Inc's full reported history, from 2020 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 22M to -$ 162M. Revenue increased in 0% of the years measured; net income in 17%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 10.44 | — |
1 Year2025-08-12 | $ 5.31 | 96.61% |
5 Years2021-08-12 | $ 27.32 | -61.79% |
All Time2020-11-19 | $ 49.00 | -78.69% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2020-11-19 |
|---|---|---|---|---|
| Price | $ 10.44 | $ 5.31 | $ 27.32 | $ 49.00 |
| Return | — | 96.61% | -61.79% | -78.69% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 0.00 | -$ 204M | $ 461M |
| 2025 | $ 0.00 | -$ 162M | $ 505M |
| 2024 | $ 0.00 | -$ 129M | $ 434M |
| 2023 | $ 0.00 | -$ 96M | $ 261M |
| 2022 | $ 0.00 | -$ 102M | $ 204M |
| 2021 | $ 0.00 | -$ 71M | $ 287M |
| IPO2020 | $ 0.00 | -$ 22M | $ 338M |
Explore beyond OLMA
You're looking at Olema Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
